Livia Yap

Will the delisting trend actually turn out to be a good sign for SGX?

It creates a situation in which unlisted companies, free of the constraints of quarterly reporting, are more able to focus on long-term growth, thereby stabilizing the economy.

Singapore tycoon Ron Sim suspends V3 Group’s HK listing plan amid market rout

The Singapore entrepreneur took Osim International Ltd private in a $236 million buyout in 2016. V3 Group comprises the Osim business and other consumer products units.

Men-only corporate boardrooms alive and well in China, Japan

Japanese companies without any female directors include SoftBank Group, Nintendo, Uniqlo and 7-Eleven while Chinese companies with no women on their boards include Tencent, SAIC Motor and Kweichow Moutai

This Singapore entrepreneur quit own venture in rare display of succession planning

So serious is the problem that succession planning has taken off as an industry in Singapore and elsewhere in Asia, with everyone from PE funds to M&A consultants vying to help companies transition to the next generation.

From telegraph to video games, 139-year-old Singtel reinvents itself for millennials

The foray into gaming is its strategy to diversify from traditional businesses where competition is toughening.

Singtel partners Razer, Sea to launch Asia e-sports league in digital content push

Singtel, which has a market capitalization of about $40 billion, has sought to grow in new industries as competition encroaches on its traditional businesses.

Singapore’s MyRepublic mulls HK IPO as early as December 2019

Sixteen Singapore-based companies chose to list in Hong Kong last year, raising more than $800 million.

Singtel seeks to create platform to tap 50m users making mobile payments in Asia

Singtel plans to expand the platform to include mobile wallets provided by associates such as those in the Philippines, India and Indonesia,

Genting-backed Singaporean pharma startup TauRx claims $2.5b valuation

Funded by investors including casino operator Genting, TauRx Pharmaceuticals is embarking on its latest trial to find a cure for Alzheimer’s.

Yoma’s Melvyn Pun sees Myanmar as a land of exciting investment opportunities

Yoma Strategic is one of three publicly listed companies that have grown out of a business founded by the elder Pun in 1983, one of the largest conglomerates in Myanmar.